Evidence map›Paper›PMID 21245411›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2011

The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.

Anna Tury, Georges Mairet-Coello, Emanuel DiCicco-Bloom

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 77 citations in OpenAlex.

  1. A low-level Cdkn1c/p57EMBO reports · 2026
    Article
  2. p57International journal of molecular sciences · 2024
    Article
  3. Article
  4. Article
  5. p27International journal of molecular sciences · 2022
    Article
  6. Deep exploration of aJournal of medical genetics · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Requirement of PP2A-B56iScience · 2020
    Article
  13. Article
  14. Functional Versatility of the CDK Inhibitor p57Frontiers in cell and developmental biology · 2020
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anna TuryDepartment of Neuroscience and Cell Biology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA. turyanna@hotmail.com
Georges Mairet-Coello
Emanuel DiCicco-Bloom
Rutgers, The State University of New Jersey · US

Funding

PACAP REGULATION OF NEUROGENESIS AND SURVIVALR01NS032401 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI DICICCO-BLOOM, EMANUEL MURRAY · 1994 to 2009
$2.0M
NINDS NIH HHS R01 NS32401
6 · The paper itself

Abstract

Mounting evidence indicates cyclin-dependent kinase (CDK) inhibitors (CKIs) of the Cip/Kip family, including p57(Kip2) and p27(Kip1), control not only cell cycle exit but also corticogenesis. Nevertheless, distinct activities of p57(Kip2) remain poorly defined. Using in vivo and culture approaches, we show p57(Kip2) overexpression at E14.5-15.5 elicits precursor cell cycle exit, promotes transition from proliferation to neuronal differentiation, and enhances process outgrowth, while opposite effects occur in p57(Kip2)-deficient precursors. Studies at later ages indicate p57(Kip2) overexpression also induces precocious glial differentiation, suggesting stage-dependent effects. In embryonic cortex, p57(Kip2) overexpression advances cell radial migration and alters postnatal laminar positioning. While both CKIs induce differentiation, p57(Kip2) was twice as effective as p27(Kip1) in inducing neuronal differentiation and was not permissive to astrogliogenic effects of ciliary neurotrophic factor, suggesting that the CKIs differentially modulate cell fate decisions. At molecular levels, although highly conserved N-terminal regions of both CKIs elicit cycle withdrawal and differentiation, the C-terminal region of p57(Kip2) alone inhibits in vivo migration. Furthermore, p57(Kip2) effects on neurogenesis and gliogenesis require the N-terminal cyclin/CDK binding/inhibitory domains, while previous p27(Kip1) studies report cell cycle-independent functions. These observations suggest p57(Kip2) coordinates multiple stages of corticogenesis and exhibits distinct and common activities compared with related family member p27(Kip1).

Indexed as

AnimalsCell DifferentiationCell Migration InhibitionCells, CulturedCerebral CortexCyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent Kinase Inhibitor p57FemaleGene Expression Regulation, DevelopmentalMaleMiceMice, KnockoutNeural Stem CellsNeurogenesisPregnancyRatsCdkn1b protein, mouseCdkn1c protein, mouseCyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent Kinase Inhibitor p57

Identifiers

PMID21245411
PMCPMC3138513
OpenAlexW2127585547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.